Glenmark Pharmaceuticals launches nicotine replacement therapy product ‘Kwitz’

16 Nov 2017 Evaluate

Glenmark Pharmaceuticals has launched nicotine replacement therapy product ‘Kwitz’ that helps smokers quit smoking. Kwitz nicotine gum will be available in two variants of 2 mg as an OTC product and 4mg as prescription product. While Kwitz 2 mg is for those smoking less than 20 cigarettes per day, Kwitz 4 mg is meant for smokers consuming more than 20 cigarettes per day.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).


Glenmark Pharma Share Price

1917.40 -48.35 (-2.46%)
08-Dec-2025 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 920.90
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×